Bausch + Lomb Greece

Bausch + Lomb Greece company information, Employees & Contact Information

ΒAUSCH + LOMB Greece is a multinational pharmaceutical company that manufactures a broad range of branded pharmaceuticals, over-the-counter (OTC) products and medical devices. Founded in 1853, we have significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. We have a diversified portfolio of products, with a core focus in the areas of Eye Health and General Health. In Greece, some of the most reputable products are Biotrue®, Renu®, Niflamol®, Counterpain®, Ezixin®, Ocuvite®, Vidilac®, Artelac® & Dexamytrex®. Every day, our products are trusted by 150 million people globally. In BAUSCH + LOMB, our mission is to help people see better and live better all over the world—that’s why we started and what we still strive for today. Through unwavering focus rooted in innovation, quality and craftsmanship, we continue to pursue our lifelong vision of protecting and enhancing the gift of sight through every phase of life. In April 2018, BAUSCH + LOMB became the first pharmaceutical company in Europe to be certified with ISO 37001 in anti-bribery management systems. Most importantly, BAUSCH + LOMB Greece is a Great Place to Work® Hellas winning company, with a 3rd Best Workplaces 2022 award, in the category of companies with 50-250 employees.

Company Details

Employees
26
Founded
-
Address
53 Leoforos Pentelis, Vrilissia,attiki 152 35,greece
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Vrilissia, Attiki
Looking for a particular Bausch + Lomb Greece employee's phone or email?

Bausch + Lomb Greece Questions

News

Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio - PR Newswire

Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio PR Newswire

Why Bausch Health Companies Inc. stock is rated strong buy - July 2025 Levels & Daily Momentum Trading Reports - Trung tâm Dự báo KTTV quốc gia

Why Bausch Health Companies Inc. stock is rated strong buy - July 2025 Levels & Daily Momentum Trading Reports Trung tâm Dự báo KTTV quốc gia

Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes - Yahoo Finance

Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes Yahoo Finance

Bausch Health: Repricing Continues As Deleveraging Gains Traction (NYSE:BHC) - Seeking Alpha

Bausch Health: Repricing Continues As Deleveraging Gains Traction (NYSE:BHC) Seeking Alpha

19.13% Ownership Stake: Bausch Health Chairman Paulson Acquires Icahn's Entire Position in Major Shakeup - Stock Titan

19.13% Ownership Stake: Bausch Health Chairman Paulson Acquires Icahn's Entire Position in Major Shakeup Stock Titan

Bausch Health bags phase 3-ready liver prospect in $63M Durect buyout - Fierce Biotech

Bausch Health bags phase 3-ready liver prospect in $63M Durect buyout Fierce Biotech

Billionaire Carl Icahn builds 34% economic interest in Bausch Health - Reuters

Billionaire Carl Icahn builds 34% economic interest in Bausch Health Reuters

Ex-BMS General Counsel Joins Bausch Health Board - Law360

Ex-BMS General Counsel Joins Bausch Health Board Law360

Bausch Health Learns Icahn Has 34% Economic Interest in Shares - The Wall Street Journal

Bausch Health Learns Icahn Has 34% Economic Interest in Shares The Wall Street Journal

Bausch Health, after setting up 'poison pill' defense, reveals activist investor Carl Icahn's 34% interest - Fierce Pharma

Bausch Health, after setting up 'poison pill' defense, reveals activist investor Carl Icahn's 34% interest Fierce Pharma

Fitch Upgrades Bausch + Lomb, Bausch Health But Keeps Both Junk - Bloomberg.com

Fitch Upgrades Bausch + Lomb, Bausch Health But Keeps Both Junk Bloomberg.com

Bausch Health Announces the Appointment of Two New Members to Its Board of Directors - Yahoo Finance

Bausch Health Announces the Appointment of Two New Members to Its Board of Directors Yahoo Finance

Why Bausch Health Stock Surged By Nearly 20% (NYSE:BHC) - Seeking Alpha

Why Bausch Health Stock Surged By Nearly 20% (NYSE:BHC) Seeking Alpha

Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025 - Yahoo Finance

Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025 Yahoo Finance

Bausch Health: Repricing Potential Driven By Deleveraging (NYSE:BHC) - Seeking Alpha

Bausch Health: Repricing Potential Driven By Deleveraging (NYSE:BHC) Seeking Alpha

Is Bausch Health Companies (BHC) the Ridiculously Cheap Stock to Invest in? - Yahoo Finance

Is Bausch Health Companies (BHC) the Ridiculously Cheap Stock to Invest in? Yahoo Finance

Bausch + Lomb And Bausch Health: Some Incremental Progress As We Wait For Sale News (BLCO) - Seeking Alpha

Bausch + Lomb And Bausch Health: Some Incremental Progress As We Wait For Sale News (BLCO) Seeking Alpha

Bausch Health Companies Inc. (BHC): Among Billionaire John Paulson’s Stocks with Huge Upside Potential - Yahoo Finance

Bausch Health Companies Inc. (BHC): Among Billionaire John Paulson’s Stocks with Huge Upside Potential Yahoo Finance

Bausch Health Companies: Improving Core Business Cures Its Bankruptcy Rumors - Seeking Alpha

Bausch Health Companies: Improving Core Business Cures Its Bankruptcy Rumors Seeking Alpha

Bausch Health to Announce Third Quarter 2025 Results on October 29 - Yahoo Finance

Bausch Health to Announce Third Quarter 2025 Results on October 29 Yahoo Finance

Bausch Health Announces Results of Special Meeting of Shareholders - Yahoo Finance

Bausch Health Announces Results of Special Meeting of Shareholders Yahoo Finance

Bausch Health Companies Inc. (BHC): A Bull Case Theory - Yahoo Finance

Bausch Health Companies Inc. (BHC): A Bull Case Theory Yahoo Finance

Revenue of Bausch Health Companies from 2020 to 2024 - Statista

Revenue of Bausch Health Companies from 2020 to 2024 Statista

Bausch Health Companies (BHC) Canada Announces Expanded Availability of CABTREO Gel - Yahoo Finance

Bausch Health Companies (BHC) Canada Announces Expanded Availability of CABTREO Gel Yahoo Finance

Bausch Health Companies First Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance

Bausch Health Companies First Quarter 2025 Earnings: EPS Misses Expectations Yahoo Finance

Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds - Yahoo Finance

Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds Yahoo Finance

Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors - CNBC

Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors CNBC

Bausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease Treatment - Yahoo Finance

Bausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease Treatment Yahoo Finance

With 51% institutional ownership, Bausch Health Companies Inc. (NYSE:BHC) is a favorite amongst the big guns - Yahoo Finance

With 51% institutional ownership, Bausch Health Companies Inc. (NYSE:BHC) is a favorite amongst the big guns Yahoo Finance

Eyecare company Bausch + Lomb explores sale to end messy spin-off - Financial Times

Eyecare company Bausch + Lomb explores sale to end messy spin-off Financial Times

Bausch Health And Bausch + Lomb Corporation Announce Closing Of Initial Public Offering Of Bausch + Lomb And Related Debt Transactions - PR Newswire

Bausch Health And Bausch + Lomb Corporation Announce Closing Of Initial Public Offering Of Bausch + Lomb And Related Debt Transactions PR Newswire

Bausch Health Tussles With Activist Investor Carl Icahn After Popping Poison Pill - BioSpace

Bausch Health Tussles With Activist Investor Carl Icahn After Popping Poison Pill BioSpace

Bausch Health Announces Thomas J. Appio As Chief Executive Officer - PR Newswire

Bausch Health Announces Thomas J. Appio As Chief Executive Officer PR Newswire

Bausch Health (BHC CN) Taps Jefferies to Refinance Debt, Aid Spinoff - Bloomberg.com

Bausch Health (BHC CN) Taps Jefferies to Refinance Debt, Aid Spinoff Bloomberg.com

BHC INVESTOR NOTICE: Bausch Health Companies Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire

BHC INVESTOR NOTICE: Bausch Health Companies Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PR Newswire

Drugmaker 340B contract pharmacy restrictions continue with Bausch Health - Fierce Healthcare

Drugmaker 340B contract pharmacy restrictions continue with Bausch Health Fierce Healthcare

Bausch Health stock rises on insider purchase (BHC:NYSE) - Seeking Alpha

Bausch Health stock rises on insider purchase (BHC:NYSE) Seeking Alpha

Private Equity Buyout Rejected: Inside Bausch Health's Strategic Decision on Bausch + Lomb - Stock Titan

Private Equity Buyout Rejected: Inside Bausch Health's Strategic Decision on Bausch + Lomb Stock Titan

Bausch Health Companies Inc. 2025 Q1 - Results - Earnings Call Presentation (NYSE:BHC) 2025-04-30 - Seeking Alpha

Bausch Health Companies Inc. 2025 Q1 - Results - Earnings Call Presentation (NYSE:BHC) 2025-04-30 Seeking Alpha

Bausch Health: Bankruptcy Rumors Scotched For Now, But May Persist (NYSE:BHC) - Seeking Alpha

Bausch Health: Bankruptcy Rumors Scotched For Now, But May Persist (NYSE:BHC) Seeking Alpha

Why Bausch Health Companies Stock Dived by More Than 7% Today - The Motley Fool

Why Bausch Health Companies Stock Dived by More Than 7% Today The Motley Fool

Bausch Health Plans IPO of Solta Medical Aesthetics Unit - Bloomberg.com

Bausch Health Plans IPO of Solta Medical Aesthetics Unit Bloomberg.com

Bausch Health pulls the plug on Solta Medical IPO and 3-way company split - Fierce Biotech

Bausch Health pulls the plug on Solta Medical IPO and 3-way company split Fierce Biotech

Hacker Breaches Pharma Giant Bausch Health, Wants to Extort DEA - 404 Media

Hacker Breaches Pharma Giant Bausch Health, Wants to Extort DEA 404 Media

Why Bausch Health Stock Plunged After Posting First Quarter 2024 Results - Seeking Alpha

Why Bausch Health Stock Plunged After Posting First Quarter 2024 Results Seeking Alpha

Bausch Health's XIFAXAN Selected for Medicare Price Negotiations Starting 2027 - Stock Titan

Bausch Health's XIFAXAN Selected for Medicare Price Negotiations Starting 2027 Stock Titan

Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc. - PR Newswire

Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc. PR Newswire

Layoff Tracker: Ferring Will Lay Off 64 Employees in New Jersey - BioSpace

Layoff Tracker: Ferring Will Lay Off 64 Employees in New Jersey BioSpace

Bausch Health Companies Inc. Completes Name Change - PR Newswire

Bausch Health Companies Inc. Completes Name Change PR Newswire

Valeant Pharmaceuticals to Change Its Name to Bausch Health - WSJ - The Wall Street Journal

Valeant Pharmaceuticals to Change Its Name to Bausch Health - WSJ The Wall Street Journal

Bausch Health Companies Inc. Completes Name Change - MultiVu

Bausch Health Companies Inc. Completes Name Change MultiVu

Bausch Health: Severance Packages - Samfiru Tumarkin LLP

Bausch Health: Severance Packages Samfiru Tumarkin LLP

Bausch Health Cos (BHC) Stock Price, News & Analysis - MarketBeat

Bausch Health Cos (BHC) Stock Price, News & Analysis MarketBeat

Health Canada Approves ARAZLO™ (Tazarotene) Lotion, 0.045%, First Such Lotion Treatment For Acne Vulgaris - PR Newswire Canada

Health Canada Approves ARAZLO™ (Tazarotene) Lotion, 0.045%, First Such Lotion Treatment For Acne Vulgaris PR Newswire Canada

Bausch Health's Canadian business positioned for growth in 2019 - PR Newswire Canada

Bausch Health's Canadian business positioned for growth in 2019 PR Newswire Canada

Top Bausch + Lomb Greece Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant